Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
This study is ongoing, but not recruiting participants.
Study NCT00006113 Information provided by National Cancer Institute (NCI)
First Received: August 3, 2000 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma (Skin)
Additional conditions recognized in this trial
Melanoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
MART-1 antigen
aldesleukin
gp100 antigen
recombinant CD40-ligand
recombinant interferon gamma
recombinant interleukin-4
sargramostim
tyrosinase peptide
Candida albicans skin test reagent
Additional drug interventions recognized in this trial
Interferon Type II
Interferon-gamma, Recombinant
Interferons
Interleukin-4
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antirheumatic Agents
Antiviral Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
USC/Norris Comprehensive Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
